임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Multiple MyelomaA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Crohn DiseaseA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Crohn DiseaseA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Lupus Erythematosus, SystemicA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 3상모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중· Metastatic Castration-resistant Prostate NeoplasmsA Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
리드: 얀센(J&J)
- 3상모집 중· Leukemia, Myeloid, AcuteA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticA Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중· Thrombocytopenia, Neonatal AlloimmuneA Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
리드: 얀센(J&J)
- 3상모집 중· Thrombocytopenia, Neonatal AlloimmuneA Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
리드: 얀센(J&J)
- 3상모집 중· Crohns DiseaseA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorPhase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Non-Muscle Invasive Bladder NeoplasmsA Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
리드: 얀센(J&J)
- 3상모집 중· Crohn's DiseaseA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중· Multiple MyelomaA Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Colitis, UlcerativeA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Hemolytic Disease of the Fetus and NewbornA Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Metastatic Castrate-sensitive Prostate CancerA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Atrial FibrillationA Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Relapsed or Refractory Multiple MyelomaA Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Ischemic Stroke; Ischemic Attack, TransientA Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Colitis, UlcerativeA Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, JuvenileA Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Advanced or Metastatic Non-small Cell Lung CancerA Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Crohn DiseaseA Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Crohn DiseaseA Long-term Extension Study of Ustekinumab in Pediatric Participants
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticGuselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisA Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticA Study of Guselkumab in Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Chronic Lymphoid LeukemiaIbrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
협력: 애브비, 얀센(J&J), 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.